foxo4-dri peptide senolytic animal model 2023 UK | Research The FOXO4 peptide in a
The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI 5mg 99 EU COA, fast EU shipping PeptidLabs foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI alleviates RIPF. (A) Representative Western blot for the Download Scientific Diagram
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3




